港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

醫美概念股

937.304

-14.539-1.53%

漲家數：2

跌家數：8

平家數：3

市盈率：- -

高：961.507

開：951.300

低：934.949

收：951.843

成交量：9,727.81萬

成交額：5.25億

市值：1,538.96億

流通市值：1,159.44億

資料載入中...

總覽新聞資訊

港股異動 | 三生製藥(01530)升逾7% 上半年經調整的經營性歸母淨利按年增長26.5%

三生製藥發布2026中期業績：創新驅動、合作共贏、行穩致遠

三生製藥(01530.HK)發布中期業績，股東應占溢利11.47億元按年減少15.58%

三生製藥(01530)出現大手買入46.15萬股，成交價$16.52，涉資762.398萬

阿斯达克财经

港股異動 | 四環醫藥(00460)升逾6% 上半年淨利預增不低於217.2% 公司醫美業務進入快速放量階段

復星醫藥(02196)股價上升8.483%，現價港幣$18.16

阿斯达克财经

港股創新藥概念股集體走強，中國生物製藥升逾20%，石藥集團升逾16%

老虎资讯综合

國家藥監局批准三生製藥非甾體抗炎藥上市

復鋭醫療科技2026年中期經營展現穩健發展韌性

復鋭醫療科技(01696)公布中期業績母公司擁有人應占虧損115.5萬美元按年盈轉虧

卓珈控股(01827)股價上升5.263%，現價港幣$0.8

阿斯达克财经

高盛：下調康哲藥業(00867.HK)目標價至17.96港元維持「買入」評級

卓珈控股(01827)股價顯著下跌12.5%，現價港幣$0.7

阿斯达克财经

《股市簡訊》中國康哲藥業漲4%，宣派中期股息按年增5.1%

康哲藥業：上半年營業額增長12.5%至45.01億元

康哲藥業(00867.HK)將於9月8日派發中期股息每股0.189港元

康哲藥業(00867)公布中期業績公司擁有人應占溢利按年增長4.77%至9.86億元

智通财经网

復星醫藥子公司攜生物類似藥出海牽手全球仿製藥龍頭，鎖定四成銷售分成

每日经济新闻

復星醫藥(02196.HK)控股子公司復宏漢霖與Sandoz AG簽訂合作框架協議並達成許可

復星醫藥擬與山德士合作，共同推進多達10款生物藥的商業化、開發與生產

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/BK1593/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":937.30426,"timestamp":1787723366840,"preClose":951.843,"halted":0,"volume":97278148,"delay":0,"changeRate":-0.015274,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-14.538757,"latestTime":"08-26 13:49:27","open":951.2996,"high":961.5065,"low":934.9491,"amount":525045846,"amplitude":0.027901,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787731800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787707800000,1787716800000],[1787720400000,1787731200000]],"pbRate":1.210361,"peRate":11.275622,"turnoverRate":0.004872,"increases":2,"decrements":8,"flats":3,"marketCap":153895608344,"floatMarketCap":115943844376},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":961.5065,"amplitude":0.027901,"preClose":951.843,"low":934.9491,"pbRate":"1.210361","latestPrice":937.30426,"volume":97278148,"delay":0,"open":951.2996,"prevYearClose":1094.978,"prevWeekClose":957.756,"prevMonthClose":920.614,"prevQuarterClose":846.145,"fiveDayClose":932.26,"twentyDayClose":940.305,"sixtyDayClose":925.34,"secType":"PLATE","market":"HK","turnoverRate":0.004872,"peRate":11.275622,"marketCap":153895608344,"floatMarketCap":115943844376,"timestamp":1787723366840,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":2,"down":8,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661598772","title":"港股異動 | 三生製藥(01530)升逾7% 上半年經調整的經營性歸母淨利按年增長26.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661598772","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661598772?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 10:22","pubTimestamp":1787278953,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药(01530)涨超7%，截至发稿，涨6.85%，报17.63港元，成交额3.95亿港元。消息面上，三生制药发布2026年中期业绩。上半年公司实现营业收入45.3亿元，同比增长3.9%；归母净利润11.5亿元，同比减少15.58%；经调整的经营性归母净利润14.4亿元，同比增长26.5%。上半年核心品种获全球23个国家上市许可，海外产品销售同比增长43%，来源于公司rhEPO、益赛普、rhTPO等品种在全球多个新兴经济体国家提升市场渗透率。集团预期于可预见未来人民币汇率波动对经营并无重大不利影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483085.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK1583","01530","BK1593","HK0000165453.HKD","BK1161","BK4585","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233703","title":"三生製藥發布2026中期業績：創新驅動、合作共贏、行穩致遠","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233703","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233703?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 23:17","pubTimestamp":1787239022,"startTime":"0","endTime":"0","summary":"三生制药今日发布2026年中期业绩公告。今年上半年，公司实现营业收入45.3亿元，同比增长3.9%，归母净利润11.5亿元，经调整的经营性归母净利润14.4亿元，同比增长26.5%，研发费用6.8亿元，同比增长24.9%，公司财务资源194亿元，充裕的资金储备为研发投入和战略布局提供了坚实保障。上半年核心品种获全球23个国家上市许可，海外产品销售同比增长43%，来源于公司rhEPO、益赛普、rhTPO等品种在全球多个新兴经济体国家提升市场渗透率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260820/32341912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01530","BK1593","HK0000165453.HKD","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660238133","title":"三生製藥(01530.HK)發布中期業績，股東應占溢利11.47億元 按年減少15.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660238133","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660238133?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 22:33","pubTimestamp":1787236399,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HK0000165453.HKD","BK1583","BK1593","01530","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660404750","title":"三生製藥(01530)出現大手買入46.15萬股，成交價$16.52，涉資762.398萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2660404750","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660404750?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:59","pubTimestamp":1787212740,"startTime":"0","endTime":"0","summary":"[大手成交]三生制药(01530)在下午03:59出现大手买入，成交量为46.15万，成交价为港币$16.52，涉资762.398万。至目前为止，股价跌1.019%，今日最高价为$17.85，而最低价为$16.34，总成交量为5.623千万股，总成交金额港币$9.607亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2608206016/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2608206016/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01530","HK0000165453.HKD","BK1161","BK1593","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660406619","title":"港股異動 | 四環醫藥(00460)升逾6% 上半年淨利預增不低於217.2% 公司醫美業務進入快速放量階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2660406619","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660406619?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 14:18","pubTimestamp":1787206705,"startTime":"0","endTime":"0","summary":"消息面上，近期，四环医药业绩盈喜预告，集团预期于截至2026年6月30日止六个月取得收入不低于人民币11.4亿元，与去年同期大致持平；取得期内净利润不低于人民币2.1亿元，较去年同期增长不低于217.2%。该行认为，公司医美业务进入快速放量阶段，创新药及其他药品、仿制药业务盈利有望改善，公司经营拐点已至。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK1515","KCAI","BK1191","BK4585","BK4588","BK1593","00460","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660477052","title":"復星醫藥(02196)股價上升8.483%，現價港幣$18.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2660477052","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660477052?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 10:33","pubTimestamp":1787193180,"startTime":"0","endTime":"0","summary":"[上升股]复星医药(02196) 股价在上午10:33比前收市价上升8.483%，现股价为港币$18.16。至目前为止，今日最高价为$18.16，而最低价为$17.42。总成交量为597.604万股，总成交金额为港币$1.069亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608202496/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608202496/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0012","BK0060","600196","BK0239","BK0028","BK0187","BK0196","BK0183","BK1191","BK1515","BK1593","BK0188","BK0175","02196","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162366260","title":"港股創新藥概念股集體走強，中國生物製藥升逾20%，石藥集團升逾16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162366260","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162366260?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 09:59","pubTimestamp":1787191169,"startTime":"0","endTime":"0","summary":"8月20日，港股创新药概念股集体走强，$中国生物制药(01177)$涨超20%，$石药集团(01093)$涨超16%，$晶泰控股(02228)$、$金斯瑞生物科技(01548)$涨超12%，$乐普生物(02157)$、$康方生物(09926)$涨超11%，$荣昌生物(09995)$、$复星医药(02196)$涨超7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1191","LU2399975544.HKD","BK1583","LU0880133367.SGD","LNGR","LU0315179316.USD","LU0417516738.SGD","LU1993786604.SGD","IBBQ","LU0540923850.HKD","LU0561508036.HKD","LU1794554557.SGD","BK1617","BK1521","LU0348827113.USD","LU1226288253.USD","LU2778985437.USD","LU1226287529.USD","LU0326950275.SGD","06978","02196","LU2476274720.SGD","LU2476274308.USD","IE00BZ08YR35.GBP","HK0000306685.HKD","09926","IE00B5MMRT66.SGD","159992","LU1152091168.USD","VXUS","IE00B543WZ88.USD","LU0348783233.USD","LU1152091754.HKD","LU1813983027.USD","LU0348825331.USD","BK1161","HK0000320223.HKD","LU0140636845.USD","LU0348735423.USD","SG9999004220.SGD","LU1951186391.HKD","HK0000306701.USD","IE0008368742.USD","BK1141","IE00BZ08YS42.EUR","09995","LU0501845795.SGD","LU1807302812.USD","KCAI","LU1969619763.USD","BK1574","LU0348784397.USD","BK1515","BK1593","IE0008369823.USD","02228","LU0348766576.USD","LU2039709279.SGD","IE00B031HY20.USD","HK0000165453.HKD","LU1008478684.HKD","LU0417516902.SGD","LU0072913022.USD","01548","KURE","LU0348767384.USD","MEDX","LU0314109678.HKD","01177","LU0417516571.SGD","LU1226287875.USD","LU1328277881.USD","01093","LU1226288170.HKD","BK1589","LU2488822045.USD","IE00BPRC5H50.USD","LU1720050803.USD","LU1960683339.HKD","LU0067412154.USD","LU2328871848.SGD","LU1961090484.USD","BK1576","LU1226287792.SGD","HK0000320264.USD","02157","LU0634319403.HKD","IE00BZ08YT58.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153271973","title":"國家藥監局批准三生製藥非甾體抗炎藥上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1153271973","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153271973?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 09:59","pubTimestamp":1787191149,"startTime":"0","endTime":"0","summary":"国家药品监督管理局正式批准了三生制药旗下非甾体抗炎药物的上市申请。这一决定标志着该药物在完成严格的临床研究与审评流程后，获得了进入中国市场的通行证。值得注意的是，非甾体抗炎药作为临床常用的镇痛消炎类药物，其市场潜力与治疗价值备受关注。业内人士指出，该药物的获批将进一步增强三生制药在抗炎镇痛领域的竞争力。三生制药方面表示，将持续致力于高质量药物的研发与生产，以满足未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","BK1593","HK0000165453.HKD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428277","title":"復鋭醫療科技2026年中期經營展現穩健發展韌性","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428277","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660428277?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 20:00","pubTimestamp":1787140800,"startTime":"0","endTime":"0","summary":"注射填充业务高速增长，亚太市场驱动国际收入稳步上行 香港2026年8月19日 /美通社/ -- 复锐医疗科技有限公司，一家全球化的美丽健康集团，致力于以能量源设备及注射填充产品为核心构建客户导向的美丽健康生态系统，今日公布截至2026年6月30日止六个月之未经审核综合中期业绩。毛利率为56.7%，2025年同期为60.0%。净利润率为0.6%，2025年同期为5.4%。经调整净利润为5.0百万美元，2025年同期为12.0百万美元。\" 复锐医疗科技首席执","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5029388_ZH29388_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5029388_ZH29388_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1585","BK1593","01696","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660344741","title":"復鋭醫療科技(01696)公布中期業績 母公司擁有人應占虧損115.5萬美元 按年盈轉虧","url":"https://stock-news.laohu8.com/highlight/detail?id=2660344741","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660344741?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 19:14","pubTimestamp":1787138058,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复锐医疗科技(01696)公布2026年中期业绩，收益为约1.714亿美元，同比增加3.6%。母公司拥有人应占亏损115.5万美元，同比盈转亏;每股亏损0.25美仙。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482106.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1585","01696","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660443371","title":"卓珈控股(01827)股價上升5.263%，現價港幣$0.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2660443371","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660443371?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 15:45","pubTimestamp":1787125500,"startTime":"0","endTime":"0","summary":"[上升股]卓珈控股(01827) 股价在下午03:45比前收市价上升5.263%，现股价为港币$0.8。至目前为止，今日最高价为$0.8，而最低价为$0.78。总成交量为8.5万股，总成交金额为港币$6.68万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608192808/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608192808/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01827","BK1593","BK1215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660239417","title":"高盛：下調康哲藥業(00867.HK)目標價至17.96港元 維持「買入」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2660239417","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660239417?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 14:24","pubTimestamp":1787120679,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BVYPNQ40.USD","00867","SG9999015986.USD","IE00BVYPNP33.GBP","SG9999015978.USD","BK1593","SG9999015952.SGD","BK1191","IE00BMCWC346.EUR","SG9999015945.SGD","IE00BYV24P56.USD","SG9999004220.SGD","LU2488822045.USD","IE00BGHQDM52.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660603459","title":"卓珈控股(01827)股價顯著下跌12.5%，現價港幣$0.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2660603459","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660603459?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 11:15","pubTimestamp":1787022900,"startTime":"0","endTime":"0","summary":"[下跌股]卓珈控股(01827) 股价在上午11:15比前收市价显著下跌12.5%，现股价为港币$0.7。至目前为止，今日最高价为$0.76，而最低价为$0.7。总成交量为12万股，总成交金额为港币$8.752万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2608182260/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2608182260/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1593","01827","BK1215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660845625","title":"《股市簡訊》中國康哲藥業漲4%，宣派中期股息按年增5.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660845625","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660845625?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 10:47","pubTimestamp":1787021249,"startTime":"0","endTime":"0","summary":"《股市简讯》中国康哲药业涨4%，宣派中期股息同比增5.1%* 中国康哲药业0867.HK周二早盘涨4%。* 该公司上日公告称，上半年公司拥有人应占期间溢利9.9亿元人民币，同比增4.8%，主要因为创新及独家产品驱动增长。宣派中期股息每股0.1634元，同比增长5.1%。* 康哲药业今年迄今跌5.9%，同期恒生指数.HSI下滑1.4%。* 恒生综合行业指数 - 医疗保健业.HSCIH盘中一度升1.3%。（完）更多股市简讯请点选CN-CMN-HOT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4S44F044:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","SG9999015945.SGD","SG9999015952.SGD","IE00BVYPNP33.GBP","00867","SG9999015978.USD","IE00BYV24P56.USD","SG9999004220.SGD","BK1593","IE00BMCWC346.EUR","SG9999015986.USD","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660345573","title":"康哲藥業：上半年營業額增長12.5%至45.01億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660345573","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660345573?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 09:45","pubTimestamp":1787017500,"startTime":"0","endTime":"0","summary":"8月17日，康哲药业（00867）发布截至2026年6月30日止六个月之中期业绩公告。报告期内，公司营业额同比增长12.5%至45.01亿元，若全按药品销售收入计算则营业额同比增长14.4%至53.41亿元。毛利同比增长11.4%至32.21亿元，毛利率为71.6%。期间溢利同比增长4.3%至9.72亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608183844237558.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608183844237558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BMCWC346.EUR","00867","LU2488822045.USD","SG9999004220.SGD","SG9999015986.USD","BK1593","SG9999015952.SGD","BK1191","IE00BGHQDM52.EUR","SG9999015945.SGD","IE00BYV24P56.USD","IE00BVYPNQ40.USD","SG9999015978.USD","IE00BVYPNP33.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660382734","title":"康哲藥業(00867.HK)將於9月8日派發中期股息每股0.189港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660382734","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660382734?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 21:30","pubTimestamp":1786973419,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SG9999015952.SGD","SG9999015978.USD","BK1593","IE00BYV24P56.USD","BK1191","SG9999004220.SGD","SG9999015986.USD","LU2488822045.USD","IE00BVYPNQ40.USD","SG9999015945.SGD","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP","00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660497438","title":"康哲藥業(00867)公布中期業績 公司擁有人應占溢利按年增長4.77%至9.86億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660497438","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660497438?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 21:28","pubTimestamp":1786973287,"startTime":"0","endTime":"0","summary":"康哲药业(00867)公布2026年中期业绩，营业额同比增长 12.5%至约45亿元，毛利同比增长 11.4%至约32.21亿元，期间溢利同比增长 \n4.3%至9.715亿元，公司拥有人应占溢利同比增长4.77%至9.86亿元，每股基本盈利0.4075 元，中期股息每股0.1634元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg15.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg15.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481036.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康哲药业(00867)公布中期业绩 公司拥有人应占溢利同比增长4.77%至9.86亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1593","SG9999004220.SGD","00867","IE00BVYPNP33.GBP","SG9999015952.SGD","SG9999015986.USD","IE00BGHQDM52.EUR","SG9999015945.SGD","BK1191","SG9999015978.USD","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","LU2488822045.USD","IE00BYV24P56.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660866704","title":"復星醫藥子公司攜生物類似藥出海 牽手全球仿製藥龍頭，鎖定四成銷售分成","url":"https://stock-news.laohu8.com/highlight/detail?id=2660866704","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660866704?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 17:26","pubTimestamp":1786958770,"startTime":"0","endTime":"0","summary":"8月17日，复星医药（SH600196，股价24.01元，市值588.9亿元）公告披露，其控股子公司复宏汉霖与全球生物类似药龙头SandozAG于8月16日签订《合作框架协议》。双方约定，可就复宏汉霖至多10款单克隆抗体（mAb）和/或抗体偶联药物（ADC）生物类似药，开展海外区域的注册、商业化、开发、生产等许可合作，并已就首批3款产品达成具体商业条款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173843260444.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173843260444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XPH","LU2272731782.SGD","BK4588","IBB","IE00B5TLWC47.USD","BK0183","LU1992135399.USD","BK1593","BK0187","LU2272731865.HKD","LU2272731600.USD","BK1515","BK0175","LU2322448791.USD","BK0188","600196","BK0012","BK0028","02196","LU2322448957.HKD","LU2473716301.USD","PPH","BK0096","BK0196","BK0239","BK0060","BK1191","BK4585","LU1992135472.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660059911","title":"復星醫藥(02196.HK)控股子公司復宏漢霖與Sandoz AG簽訂合作框架協議並達成許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2660059911","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660059911?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 08:34","pubTimestamp":1786926890,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02696","HK0000306701.USD","BK1515","BK1593","BK1191","HK0000320264.USD","HK0000165453.HKD","BK1161","HK0000306685.HKD","HK0000320223.HKD","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129073878","title":"復星醫藥擬與山德士合作，共同推進多達10款生物藥的商業化、開發與生產","url":"https://stock-news.laohu8.com/highlight/detail?id=1129073878","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129073878?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 08:03","pubTimestamp":1786924988,"startTime":"0","endTime":"0","summary":"复星医药宣布，计划与山德士携手，围绕多达10款生物制品展开合作。合作范围涵盖商业化、开发以及生产等关键环节。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0028","BK0187","BK1191","BK0183","BK1593","BK0196","02196","BK0239","BK0060","BK0175","BK0188","BK1515","BK0096","600196"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":51,"code":"91000000","status":"200"}]}}